Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging

Completed · Phase 4 · Has a placebo group

Conditions studied: Obesity, Visceral

In brief

This study is a clinical study to investigate the gluconeogenesis pathway related to visceral adipose tissue (VAT) in obese individuals without type 2 diabetes and the effects of empagliflozin (EMPA) on glucose homeostasis in viscerally-obese individuals using functional studies of glycerol metabolism in hepatic gluconeogenesis using a well-validated nuclear magnetic resonance (NMR) spectroscopy platform.

Key facts

Study ID
NCT02833415
Run by
University of Texas Southwestern Medical Center
People needed
40
Starts
2016-03-01
Expected to finish
2018-11-01
Last updated by the study team
2020-01-23

Who can join

Age: 30 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.